Retension Pharmaceuticals Appoints LeAnne Bloedon and Kevin Schutz as Clinical and Regulatory Leaders

Retension Pharmaceuticals has appointed LeAnne Bloedon as executive vice president of clinical development and operations and Kevin Schutz as vice... Read More

The post Retension Pharmaceuticals Appoints LeAnne Bloedon and Kevin Schutz as Clinical and Regulatory Leaders appeared first on citybiz.